Given the multiple protective effects displayed by IL-37 in NSCLC, future research should delve into its molecular mechanisms and expression and function across different types of lung cancer, as well as consider its anti-tumor activity and potential immunomodulatory effects in the development of novel therapeutic strategies (Figure 3). Here, IL37 is linked to lung carcinoma.